HemaSphere
(Jun 2022)
P397: PROLACTIN RECEPTOR CONFERS CHEMORESISTANCE DUE TO SENESCENCE ENTRANCE IN ACUTE MYELOID LEUKEMIA
- L. Cuesta-Casanovas,
- J. M. Cornet-Masana,
- J. M. Carbó,
- J. Delgado-Martínez,
- L. Clément-Demange,
- A. Banús-Mulet,
- F. Guijarro,
- J. Esteve,
- R. M. Risueño
Affiliations
- L. Cuesta-Casanovas
- 1 Leukemia Stem Cell, Josep Carreras Leukemia Research Institute, Badalona
- J. M. Cornet-Masana
- 1 Leukemia Stem Cell, Josep Carreras Leukemia Research Institute, Badalona
- J. M. Carbó
- 1 Leukemia Stem Cell, Josep Carreras Leukemia Research Institute, Badalona
- J. Delgado-Martínez
- 1 Leukemia Stem Cell, Josep Carreras Leukemia Research Institute, Badalona
- L. Clément-Demange
- 4 Leukos Biotech, Barcelona
- A. Banús-Mulet
- 5 Josep Carreras Leukemia Research Institute, Badalona
- F. Guijarro
- 6 Faculty of Medicine, University of Barcelona
- J. Esteve
- 5 Josep Carreras Leukemia Research Institute, Badalona
- R. M. Risueño
- 1 Leukemia Stem Cell, Josep Carreras Leukemia Research Institute, Badalona
- DOI
-
https://doi.org/10.1097/01.HS9.0000844476.52377.f5
- Journal volume & issue
-
Vol. 6
pp.
297
– 298
WeChat QR code